About
Services
Industries
Press & insights
resources
contact
We're on a mission to help companies of all sizes identify the best locations, secure incentives, obtain development approvals and optimize energy strategies through Location Economics®.
BLS & Co. serves as location and incentives advisor to Roche, Swiss multinational healthcare leader, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012, supporting over $2.7 billion in announced investments.
BLS & Co. serves aslocation and incentives advisor to Roche, Swiss multinational healthcare company, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012 with four major projects announced as of 2026:
BLS & Co. utilizes an assortment of services – a process we call Location Economics® – to advise clients on location decisions. Discover our variety of offerings to help you navigate the complex decision making processes that occur when searching for a new location for your organization.
BLS & Co. specializes in a variety of industries and our dedicated team is compromised of experts in nearly all major categories.
At BLS & Co., we have executed wide variety of projects for our clients, which includes facilities such as headquarters, warehouses, and data centers.
Stay up to date with BLS & Co. by exploring our latest news and musings on the world of site selection and more.
We're proud to provide a few key resources to help get you started on your site selection journey.
Search our North American database for the right location for your company's HQ, R&D Facilities, and more.
Browse our regional resource guide for site selection in the U.S.
If your organization is confronting complex and sensitive location decisions, please reach out to schedule a confidential conversation.
Interested in a career opportunity with BLS & Co.? Click below to learn more about our growing team and view all current openings.
For international investors, choosing a location in 2026 is no longer a simple comparison of labor costs, taxes and incentives. Trade exposure, power availability, workforce depth and execution risk increasingly determine whether a site can support the business case.
Foreign and even domestic companies often have unrealistic expectations about site and building availability.
“After the post-COVID industrial boom and subsequent softening, the U.S. and Canadian markets have largely normalized, but much of the best inventory—especially development-ready sites—has been absorbed,” observes Tracey Hyatt Bosman, CEcD, CRE, CSSC, Managing Director, Biggins Lacy Shapiro & Company in Princeton, NJ. “Because manufacturing facilities are often highly customized, existing buildings may not fit, making new construction on a ready site necessary. Companies should therefore be prepared to compromise on location, size, cost, timing, or configuration.”
Site readiness, encompassing everything from environmental conditions to permitting to zoning, is critical, but too often overlooked, says Bosman. Close coordination with local utilities has also become an increasingly critical piece of the site readiness picture as it is vital that all parties are on the same page regarding the ability of any given site to meet the needs of potential projects.
“In the current market conditions,” she notes, “the communities and economic development organizations that make it easy for companies to get up and running will be best positioned to compete for foreign direct investment.”
Tracey Hyatt Bosman develops and executes incentives and location selection strategies for BLS & Co.'s corporate and institutional clients. She is a certified economic developer with twenty years of professional experience across a wide range of sectors, including data centers, manufacturing, headquarters, back office and contact center operations, and logistics.
We're on a mission to help companies of all sizes identify the best locations, secure incentives, obtain development approvals and optimize energy strategies through Location Economics®.
BLS & Co. serves as location and incentives advisor to Roche, Swiss multinational healthcare leader, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012, supporting over $2.7 billion in announced investments.
BLS & Co. serves aslocation and incentives advisor to Roche, Swiss multinational healthcare company, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012 with four major projects announced as of 2026:
BLS & Co. utilizes an assortment of services – a process we call Location Economics® – to advise clients on location decisions. Discover our variety of offerings to help you navigate the complex decision making processes that occur when searching for a new location for your organization.
BLS & Co. specializes in a variety of industries and our dedicated team is compromised of experts in nearly all major categories.
At BLS & Co., we have executed wide variety of projects for our clients, which includes facilities such as headquarters, warehouses, and data centers.
Stay up to date with BLS & Co. by exploring our latest news and musings on the world of site selection and more.
We're proud to provide a few key resources to help get you started on your site selection journey.
Search our North American database for the right location for your company's HQ, R&D Facilities, and more.
Browse our regional resource guide for site selection in the U.S.
If your organization is confronting complex and sensitive location decisions, please reach out to schedule a confidential conversation.
Interested in a career opportunity with BLS & Co.? Click below to learn more about our growing team and view all current openings.
